409 related articles for article (PubMed ID: 17040907)
21. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs.
Ye S; Luo Y; Lu W; Jones RB; Linhardt RJ; Capila I; Toida T; Kan M; Pelletier H; McKeehan WL
Biochemistry; 2001 Dec; 40(48):14429-39. PubMed ID: 11724555
[TBL] [Abstract][Full Text] [Related]
22. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL; Kan M
Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
[TBL] [Abstract][Full Text] [Related]
23. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
[TBL] [Abstract][Full Text] [Related]
24. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.
Muthusamy A; Cooper CR; Gomes RR
BMC Biochem; 2010 Nov; 11():43. PubMed ID: 21047416
[TBL] [Abstract][Full Text] [Related]
25. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate.
Nishiguchi KM; Kataoka K; Kachi S; Komeima K; Terasaki H
PLoS One; 2010 Oct; 5(10):e13493. PubMed ID: 20975989
[TBL] [Abstract][Full Text] [Related]
26. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.
Xu D; Fuster MM; Lawrence R; Esko JD
J Biol Chem; 2011 Jan; 286(1):737-45. PubMed ID: 20974861
[TBL] [Abstract][Full Text] [Related]
27. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C).
Yin X; Johns SC; Lawrence R; Xu D; Reddi K; Bishop JR; Varner JA; Fuster MM
J Biol Chem; 2011 Apr; 286(17):14952-62. PubMed ID: 21343305
[TBL] [Abstract][Full Text] [Related]
29. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
Teran M; Nugent MA
J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A.
Motamed K; Blake DJ; Angello JC; Allen BL; Rapraeger AC; Hauschka SD; Sage EH
J Cell Biochem; 2003 Oct; 90(2):408-23. PubMed ID: 14505356
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells.
Richard C; Liuzzo JP; Moscatelli D
J Biol Chem; 1995 Oct; 270(41):24188-96. PubMed ID: 7592623
[TBL] [Abstract][Full Text] [Related]
32. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.
Allen BL; Filla MS; Rapraeger AC
J Cell Biol; 2001 Nov; 155(5):845-58. PubMed ID: 11724824
[TBL] [Abstract][Full Text] [Related]
33. Heparan sulfate is required for interaction and activation of the epithelial cell fibroblast growth factor receptor-2IIIb with stromal-derived fibroblast growth factor-7.
Jang JH; Wang F; Kan M
In Vitro Cell Dev Biol Anim; 1997; 33(10):819-24. PubMed ID: 9466688
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.
Nishinaga M; Ozawa T; Shimada K
J Clin Invest; 1993 Sep; 92(3):1381-6. PubMed ID: 8376590
[TBL] [Abstract][Full Text] [Related]
35. Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
Loo BM; Salmivirta M
J Biol Chem; 2002 Sep; 277(36):32616-23. PubMed ID: 12077148
[TBL] [Abstract][Full Text] [Related]
36. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
Saito A
Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
[TBL] [Abstract][Full Text] [Related]
37. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
[TBL] [Abstract][Full Text] [Related]
38. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
40. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor.
LaRochelle WJ; Sakaguchi K; Atabey N; Cheon HG; Takagi Y; Kinaia T; Day RM; Miki T; Burgess WH; Bottaro DP
Biochemistry; 1999 Feb; 38(6):1765-71. PubMed ID: 10026256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
